Modern possibilities of prevention of gastrointestinal bleeding in patients with gastric and duodenal stress ulcers
https://doi.org/10.30629/0023-2149-2023-101-9-10-505-508
Abstract
The article discusses the prevention of gastrointestinal bleeding in critically ill patients who are hospitalized in intensive care units (ICU). The main factors contributing to the occurrence of GIB in such patients are considered. The leading place among them is occupied by a stay on artificial ventilation of the lungs for > 48 hours and blood coagulopathy. Patients at high risk of developing GIB need prophylactic administration of proton pump inhibitors, H2-blockers, sucralfate, which allows to prevent the occurrence of GIB and improve the prognosis of patients.
About the Authors
A. A. Sheptulin
I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russia (Sechenov University)
Russian Federation
Russian Federation
Sheptulin Arkady A.
119991, Moscow
S. S. Kardasheva
I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russia (Sechenov University)
Russian Federation
Russian Federation
Kardasheva Svetlana S.
119991, Moscow
A. A. Kurbatova
I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russia (Sechenov University)
Russian Federation
Russian Federation
Kurbatova Anastasia A.
119991, Moscow
References
1. Spechler S.J. Peptic ulcer disease and its complications. In: Sleisenger and Fordtran’s Gastrointestinal and Liver Disease (Ed. Feldman M. et al.), 7th edition. 2002;1:747–781.
2. May A., Hahn E.G. Ulkus und Erosionen durch Streβ. In: Klinische Gastroenterologie (Hrsgb. Hahn E.G., Riemann J.F.). 3. Auflage, Thieme. 2000:763–767.
3. Plummer M.P., Blaser A.R., Deane A.M. Stress ulceration: prevalence, pathology and association with adverse outcomes. Crit. Care. 2014;18(2):213. DOI: 10.1186/cc13780
4. Buendgens L., Koch A., Tacke F. Prevention of stress-related ulcer bleeding at the intensive care unit: Risks and benefi ts of stress ulcer prophylaxis. World. J. Crit. Care Med. 2016;5(1):57–64. DOI: 10.5492/wjccm.v5.i1.57
5. Arnold C. Akute Ulkus (Stressulkus). In: Klinische Pathoрhysiologie (Hrsgb. Siegenthaler W., Blum H.E.). Thieme, 9. Aufl age. 2006:811–812.
6. Saeed M., Bass S., Chaisson N.F. Which ICU patients need stress ulcer prophylaxis? Cleve Clin. J. Med. 2022;89(7):363–367. DOI: 10.3949/ccjm.89a.21085
7. Cook D.J., Griffi th L.E., Walter S.D., Guyatt G.H., Meade M.O., Heyland D.K. et al. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit. Care. 2001;5(6):368–375. DOI: 10.1186/cc1071
8. Kanno T., Moayyedi P. Who needs gastroprotection in 2020? Curr. Treat. Options Gastroenterol. 2020;18(4):557–573. DOI: 10.1007/s11938-020-00316-9
9. Toews I., George A.T., Peter J.V., Kirubakaran R., Fontes L.E.S., Ezekiel J.P.B., Meerpohl J.J. Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units. Сochrane Database Syst. Rev. 2018;6(6):CD008687. DOI: 10.1002/14651858.CD008687.pub2
10. Krag M., Marker S., Perner A., Wettersley J., Wise M.P., Schefold L.C. et al. Pantoprazole in patients at risk for gastrointestinal bleeding in the ICU. N. Engl. J. Med. 2018;379(23):2199–2208. DOI: 10.1056/NEJMoa1714919
11. Young P.J., Bagshaw S.M., Forbes A.B., Nichol A.D., Wright P.J., Bailey M. et al. Effect of stress ulcer prophylaxis with proton pump inhibitors vs histamine-2 receptor blockers on in-hospital mortality among ICU patients receiving invasive mechanical ventilation: the PEPTIC randomized clinical trial. JAMA. 2020;323(7):616–626. DOI:10.1001/jama.2019.22190
12. Pongrasobchai S., Kridkratoke S., Nopmaneejumruslers C. Proton pump inhibitors for the prevention of stress-related mucosal disease in critically-ill patients: a meta-analysis. J. Med. Assoc. Thai. 2009;92(5):632–637.
13. Alhazzani W., Alenezu F., Jaeschke R.Z., Moayyedi P., Cook D.J. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis. Crit. Care Med. 2013;41(3):693–705. DOI: 10.1097/CCM.0b013e3182758734
14. Alshamsi F., Belley-Cote E., Cook D., Almenawer S.A., Alqahtani Z., Perri D. et al. Effi cacy and safety of proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis of randomized trials. Crit. Care. 2016;20:120. DOI: 10.1186/s13054-016-1305-6
15. Deliwala S.S., Hamid K., Goyal H., Ponnapalli A., Zayed Y., Baka A. et al. Proton pump inhibitors versus histamine-2-receptor antagonists for stress ulcer prophylaxis in critically ill patients: A meta-analysis and trial sequential analysis. J. Clin. Gastroenterol. 2022;56(3):204– 217. DOI: 10.1097/MCG.0000000000001562
Review
For citations:
Sheptulin A.A., Kardasheva S.S., Kurbatova A.A. Modern possibilities of prevention of gastrointestinal bleeding in patients with gastric and duodenal stress ulcers. Clinical Medicine (Russian Journal). 2023;101(9-10):505-508. (In Russ.) https://doi.org/10.30629/0023-2149-2023-101-9-10-505-508
Views:
366
Email this article 